Liquidia (LQDA) Operating Margin (2020 - 2026)
Liquidia's (LQDA) quarterly Operating Margin came in at 46.29% in Q1 2026, up 118171.0% year-on-year from N/an in Q1 2025, and up 115.28% quarter-over-quarter from 21.5% in Q4 2025.
Liquidia (LQDA) Operating Margin (2020 - 2026) Analysis & Trends
Liquidia's Operating Margin history runs 7 years deep, the most recent figure standing at 46.29% for Q1 2026.
- On a quarterly basis, Operating Margin rose 118171.0% year-over-year to 46.29% in Q1 2026; TTM through Mar 2026 was 15.81%, a 92021.0% increase from a year earlier, with the FY2025 full-year figure at 32.45%, up 83418.0% from the prior year.
- Operating Margin advanced to 46.29% in Q1 2026 per LQDA's latest filing, from 21.5% in the prior quarter.
- Across five years, Operating Margin topped out at 46.29% in Q1 2026 and bottomed at 1237.81% in Q4 2024.
- The 5-year median for Operating Margin is 414.43% (2022), against an average of 459.38%.
- Across the five-year window, Operating Margin slumped 76360 bps in 2024 and jumped 125932 bps in 2025, its largest moves.
- Year by year, Operating Margin stood at 121.21% in 2022, then tumbled by 381 bps to 583.45% in 2023, then sank by 112 bps to 1237.81% in 2024, then soared by 102 bps to 21.5% in 2025, then soared by 115 bps to 46.29% in 2026.
- Per Business Quant, the three latest LQDA Operating Margin figures stand at 46.29% (Q1 2026), 21.5% (Q4 2025), and 3.25% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.37% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 36.83% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -38.02% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 41.69% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -2.27% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.74% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.23% |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | 46.29% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46.29% |
| Dec 31, 2025 | 21.50% |
| Sep 30, 2025 | 3.25% |
| Jun 30, 2025 | -424.41% |
| Mar 31, 2025 | -1,135.42% |
| Dec 31, 2024 | -1,237.81% |
| Sep 30, 2024 | -656.23% |
| Jun 30, 2024 | -743.29% |
| Mar 31, 2024 | -969.08% |
| Dec 31, 2023 | -583.45% |
| Sep 30, 2023 | -404.87% |
| Jun 30, 2023 | -476.91% |
| Mar 31, 2023 | -205.48% |
| Dec 31, 2022 | -121.21% |
| Sep 30, 2022 | -279.02% |
| Jun 30, 2022 | -228.94% |
| Mar 31, 2022 | -414.43% |
| Dec 31, 2021 | -353.41% |
| Sep 30, 2021 | -222.71% |
| Jun 30, 2021 | -188.21% |